List of Excipients in API naratriptan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing naratriptan
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
GlaxoSmithKline LLC | AMERGE | naratriptan hydrochloride | 0173-0561 | CELLULOSE, MICROCRYSTALLINE | |
GlaxoSmithKline LLC | AMERGE | naratriptan hydrochloride | 0173-0561 | CROSCARMELLOSE SODIUM | |
GlaxoSmithKline LLC | AMERGE | naratriptan hydrochloride | 0173-0561 | HYPROMELLOSE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing naratriptan
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 | ANHYDROUS LACTOSE |
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 | CELLULOSE, MICROCRYSTALLINE |
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 | CROSCARMELLOSE SODIUM |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for naratriptan
Excipient focus: ANHYDROUS LACTOSE
naratriptan drug variants containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
OrchidPharma Inc | naratriptan | 42043-130 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | naratriptan hydrochloride | 0173-0561 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
naratriptan drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
OrchidPharma Inc | naratriptan | 42043-130 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
naratriptan drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
OrchidPharma Inc | naratriptan | 42043-130 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
naratriptan drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
A-S Medication Solutions | naratriptan | 50090-6162 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
OrchidPharma Inc | naratriptan | 42043-130 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
naratriptan drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
A-S Medication Solutions | naratriptan | 50090-6162 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
OrchidPharma Inc | naratriptan | 42043-130 |
Bionpharma Inc | naratriptan | 69452-340 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
naratriptan drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | naratriptan hydrochloride | 0173-0561 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
OrchidPharma Inc | naratriptan | 42043-130 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
naratriptan drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
OrchidPharma Inc | naratriptan | 42043-130 |
A-S Medication Solutions | naratriptan | 50090-6162 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
GlaxoSmithKline LLC | naratriptan hydrochloride | 0173-0561 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
naratriptan drug variants containing LACTOSE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | naratriptan hydrochloride | 0173-0561 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing LACTOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
OrchidPharma Inc | naratriptan | 42043-130 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
naratriptan drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
OrchidPharma Inc | naratriptan | 42043-130 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
naratriptan drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
OrchidPharma Inc | naratriptan | 42043-130 |
A-S Medication Solutions | naratriptan | 50090-6162 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
naratriptan drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
OrchidPharma Inc | naratriptan | 42043-130 |
A-S Medication Solutions | naratriptan | 50090-6162 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
naratriptan drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
OrchidPharma Inc | naratriptan | 42043-130 |
A-S Medication Solutions | naratriptan | 50090-6162 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
naratriptan drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
OrchidPharma Inc | naratriptan | 42043-130 |
A-S Medication Solutions | naratriptan | 50090-6162 |
Bionpharma Inc | naratriptan | 69452-340 |
>Company | >Ingredient | >NDC |
naratriptan drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | naratriptan | 0054-0278 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | naratriptan | 23155-054 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.